Somerset Trust’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-15,160
| Closed | -$1.38M | – | 150 |
|
|
2022
Q4 | $1.38M | Sell |
15,160
-2,137
| -12% | -$180K | 0.58% | 50 |
|
|
2022
Q3 | $1.31M | Sell |
17,297
-375
| -2% | -$31.1K | 0.61% | 48 |
|
|
2022
Q2 | $1.49M | Sell |
17,672
-2,437
| -12% | -$214K | 0.65% | 49 |
|
|
2022
Q1 | $1.76M | Sell |
20,109
-1,375
| -6% | -$119K | 0.68% | 46 |
|
|
2021
Q4 | $1.88M | Buy |
21,484
+199
| +0.9% | +$16.5K | 0.69% | 49 |
|
|
2021
Q3 | $1.74M | Buy |
21,285
+1,629
| +8% | +$147K | 0.71% | 50 |
|
|
2021
Q2 | $1.79M | Buy |
19,656
+65
| +0.3% | +$5.79K | 0.73% | 50 |
|
|
2021
Q1 | $1.67M | Buy |
19,591
+478
| +3% | +$42.9K | 0.72% | 50 |
|
|
2020
Q4 | $1.8M | Sell |
19,113
-7
| -0% | -$612 | 0.82% | 45 |
|
|
2020
Q3 | $1.66M | Buy |
19,120
+472
| +3% | +$40.9K | 0.84% | 46 |
|
|
2020
Q2 | $1.63M | Buy |
18,648
+913
| +5% | +$78.8K | 0.87% | 46 |
|
|
2020
Q1 | $1.46M | Buy |
17,735
+926
| +6% | +$82.6K | 0.96% | 44 |
|
|
2019
Q4 | $1.59M | Buy |
16,809
+272
| +2% | +$24.4K | 0.79% | 52 |
|
|
2019
Q3 | $1.44M | Buy |
16,537
+121
| +0.7% | +$10.9K | 0.76% | 54 |
|
|
2019
Q2 | $1.5M | Sell |
16,416
-1,494
| -8% | -$126K | 0.77% | 51 |
|
|
2019
Q1 | $1.54M | Buy |
17,910
+111
| +0.6% | +$8.91K | 0.81% | 51 |
|
|
2018
Q4 | $1.37M | Buy |
17,799
+428
| +2% | +$33.3K | 0.8% | 51 |
|
|
2018
Q3 | $1.34M | Buy |
17,371
+140
| +0.8% | +$10.3K | 0.66% | 62 |
|
|
2018
Q2 | $1.17M | Buy |
17,231
+240
| +1% | +$16.6K | 0.63% | 70 |
|
|
2018
Q1 | $1.23M | Buy |
16,991
+24
| +0.1% | +$1.83K | 0.64% | 69 |
|
|
2017
Q4 | $1.28M | Buy |
16,967
+414
| +3% | +$31.2K | 0.64% | 70 |
|
|
2017
Q3 | $1.27M | Buy |
16,553
+500
| +3% | +$37.8K | 0.68% | 64 |
|
|
2017
Q2 | $1.2M | Buy |
16,053
+1,135
| +8% | +$80.4K | 0.65% | 67 |
|
|
2017
Q1 | $992K | Buy |
14,918
+311
| +2% | +$20.7K | 0.56% | 77 |
|
|
2016
Q4 | $953K | Sell |
14,607
-698
| -5% | -$45.3K | 0.57% | 77 |
|
|
2016
Q3 | $1.08M | Buy |
15,305
+506
| +3% | +$36.9K | 0.64% | 70 |
|
|
2016
Q2 | $1.09M | Buy |
14,799
+475
| +3% | +$32.8K | 0.68% | 63 |
|
|
2016
Q1 | $929K | Buy |
14,324
+356
| +3% | +$24.2K | 0.62% | 77 |
|
|
2015
Q4 | $1.08M | Buy |
13,968
+332
| +2% | +$26.4K | 0.71% | 59 |
|
|
2015
Q3 | $1.12M | Buy |
13,636
+424
| +3% | +$37.7K | 0.79% | 51 |
|
|
2015
Q2 | $1.16M | Buy |
13,212
+874
| +7% | +$80.2K | 0.76% | 50 |
|
|
2015
Q1 | $1.09M | Buy |
12,338
+891
| +8% | +$79K | 0.72% | 50 |
|
|
2014
Q4 | $950K | Buy |
11,447
+295
| +3% | +$24.5K | 0.63% | 55 |
|
|
2014
Q3 | $941K | Buy |
11,152
+279
| +3% | +$22.6K | 0.66% | 49 |
|
|
2014
Q2 | $882K | Buy |
10,873
+797
| +8% | +$62.7K | 0.63% | 54 |
|
|
2014
Q1 | $768K | Buy |
10,076
+474
| +5% | +$34.5K | 0.59% | 58 |
|
|
2013
Q4 | $691K | Buy |
+9,602
| New | +$667K | 0.53% | 65 |
|
Other funds holding NVS
Somerset Trust's NVS Position: Q1 2023 in Review
Somerset Trust sold out of Novartis (NVS) in Q1 2023, closing a stake of 15,160 shares — an estimated $1.38M sold.
Somerset Trust first reported a position in NVS in Q4 2013 and held it in 37 quarters. The position peaked at $1.88M in Q4 2021. 1,180 funds tracked by Wall St. Rank hold NVS as of Q1 2023.
- Somerset Trust reported no remaining Novartis position as of Q1 2023 after selling out during the quarter.
- Somerset Trust sold 15,160 Novartis shares in Q1 2023, an estimated $1.38M.
- Somerset Trust first reported a position in Novartis in Q4 2013 and held it in 37 quarters.
- Somerset Trust's Novartis position peaked at $1.88M in Q4 2021.
- 1,180 funds tracked by Wall St. Rank held Novartis as of Q1 2023.
Based on Somerset Trust's 13F filing for Q1 2023, filed 5 Apr 2023.